Burcu Dogan

Dr. Burcu Dogan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2020 in Bratislava Medical Journal
Verified
Journal Article
Open access
BDBurcu Dogan
Burcu Dogan
DKD. Kaan
D. Kaan
HUH. Ulger
H. Ulger
The effect of growth factors on induction of mesenchymal stem cell to the skeletal muscle cells

19 February 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CÖCan Öner
Can Öner
BDBurcu Dogan
Burcu Dogan
STSabah Tuzun
Sabah Tuzun
AEAsiye Ekinci
Asiye Ekinci
GFGunes Feyizoglu
Gunes Feyizoglu
BBBanu Isbilen Basok
Banu Isbilen Basok
Diabetic retinopathy is a commonly observed cause of blindness and is a common problem in individuals with diabetes. Recent investigations have showed the capability of serum α-Klotho and FGF 23 in mitigating the effects of diabetic retinopathy. This study aimed to discover the correlation between FGF 23, α-Klotho, and diabetic retinopathy in type 1 diabetics. This case–control study included 63 diabetic patients and 66 healthy controls. Following an overnight duration of fasting, morning blood samples were taken from both the patient and the control groups. The serum concentrations of α-Klotho and FGF 23 were quantified. An experienced ophthalmologist inspected the retinopathy. All participants in this study have moderate non-proliferative retinopathy. A p value under 0.05 was considered statistically significant. The mean α-Klotho level for retinopathic diabetic patients was 501.7 ± 172.2 pg/mL and 579.6 ± 312.1 pg/mL for non-retinopathic diabetic patients. In comparison, α-Klotho level of the control group was 523.2 ± 265.4 pg/mL (p = 0.531). The mean of FGF 23 level did not demonstrate a significant difference (p = 0.259). The mean FGF 23 level were 75.7 ± 14.0 pg/mL, 74.0 ± 14.8 pg/mL and 79.3 ± 14.4 pg/mL in groups, respectively. In conclusion, there was no significant difference in FGF 23 and α-Klotho levels between type 1 diabetics with and without retinopathy when compared to the control group.

24 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BDBurcu Dogan
Burcu Dogan
ATAysel Toçoğlu
Aysel Toçoğlu
STSabah Tuzun
Sabah Tuzun
UAUlku Akcay
Ulku Akcay
AAAyfer Altas
Ayfer Altas
ATALİ TAMER
ALİ TAMER
Background/Objectives: Ankylosing Spondylitis (AS) is associated with increased cardiovascular disease risk due to chronic systemic inflammation. The Atherogenic Index of Plasma (AIP) and Systematic Coronary Risk Evaluation (SCORE) are valuable tools for cardiovascular risk assessment, while Klotho, an anti-aging protein with cardioprotective properties, may serve as a potential biomarker for cardiovascular health. Recent studies have shown that soluble α-Klotho contributes to vascular protection by increasing endothelial cell proliferation, reducing apoptosis, and enhancing angiogenic capacity, thereby helping to maintain microvascular integrity. We aimed to assess cardiovascular event risk in AS patients using AIP and SCORE and investigate the relationship between serum Klotho levels and these factors. Methods: A case–control study was conducted between August and September 2019. The study included 24 AS patients and 24 healthy controls aged 18 and above, with 13 females and 11 males. Results: No significant difference was found in serum Klotho levels between the AS and control groups in terms of SCORE and AI classifications. In the high-risk SCORE classification group, AI was found to be elevated at 0.42. In the AS group, Klotho levels were observed as 0.73 in the low-risk group, 0.60 in the moderate-risk group, and 0.61 in the high-risk group (p = 0.974). When evaluating HDL levels, Klotho was determined to be 7.29 ± 6.81 for HDL < 35 and 0.60 [0.33] for HDL ≥ 35 (p = 0.036). Conclusions: An AI exceeding 0.40 in the high-risk SCORE group and in patients with active disease according to the BASDAI score indicated an increased cardiovascular event risk in the AS group. Further studies are warranted regarding serum Klotho levels, HDL, and LDL subclasses in AS patients.

1 January 2019 in Medeniyet Medical Journal
Verified
Journal Article
Open access
BMBanu Mesci
Banu Mesci
MTMurat Tekin
Murat Tekin
AOAytekin Oǧuz
Aytekin Oǧuz
DKDamla Çoksert Kılıç
Damla Çoksert Kılıç
GTGonca Incemehmet Tamer
Gonca Incemehmet Tamer
AAArzu Akalın
Arzu Akalın

1 June 2021
Verified
Book
Closed access
PDF file
BKBurak Kaya
Burak Kaya
FŞFatih Şahin
Fatih Şahin
AEAli Eman
Ali Eman
SÇSavaş Çömlek
Savaş Çömlek
ZIZeynep Issı
Zeynep Issı
AÜAli Metin Ülgen
Ali Metin Ülgen